Portacaval shunt

From WikiMD's WELLNESSPEDIA

Portacaval shunt is a surgical procedure that creates a connection between the portal vein and the inferior vena cava, which are two major blood vessels in the abdomen. This procedure is typically performed to reduce high blood pressure in the portal vein (a condition known as portal hypertension) that can occur as a result of liver disease.

Indications[edit]

Portacaval shunt is primarily indicated for patients with severe portal hypertension, often due to cirrhosis of the liver. This condition can lead to life-threatening complications such as esophageal varices and gastrointestinal bleeding. The shunt can help to reduce the pressure in the portal vein and prevent these complications.

Procedure[edit]

During a portacaval shunt procedure, the surgeon makes an incision in the abdomen and locates the portal vein and the inferior vena cava. A connection is then created between these two vessels, allowing blood to flow from the portal vein directly into the inferior vena cava. This bypasses the liver, reducing the pressure in the portal vein.

Risks and Complications[edit]

As with any surgical procedure, a portacaval shunt carries some risks. These can include infection, bleeding, and complications related to anesthesia. In addition, there is a risk of hepatic encephalopathy, a condition that can cause confusion and other neurological symptoms due to the buildup of toxins in the blood that are normally removed by the liver.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.